LEADER LUBRICATING EYE

Manufacturer: CARDINAL HEALTH
Effective date: 2014-12-23
Label type: HUMAN OTC DRUG LABEL
Version: 9
Source: legacy-cache
Hydrated at: 2026-08-02 01:33:55

Label at a glance#

ProductLEADER LUBRICATING EYE

Active ingredientCARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN

Label structure10 sections

Contacts and useful links#

PhoneLabel contact1-800-200-6313

Websitewww.myleader.com

www.myleader.com

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredients Purpose

Carboxymethylcellulose Sodium 0.5%----------------------- Lubricant

Glycerin 0.9%------------------------------------------------- Lubricnat

OTC - PURPOSE SECTION

Uses

For the temporary relief of burning, irritation and discomfort due to dryness of the eye or from irritation from wind or sun.
May be used to protect against further irritation

WARNINGS SECTION

Warnings

For external use only

OTC - WHEN USING SECTION

When using this product

To avoid contamination, do not touch tip of container to any surface. Replace cap after using.
Do not use if solution changes color or gets cloudy.

OTC - STOP USE SECTION

Stop use and ask a doctor if

You feel eye pain, changes in vision, continued redness, or irritation of the eye, or if the condition worsens or persists for more than 72 hours.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center immediately.

INDICATIONS & USAGE SECTION

Directions

Put 1 or 2 drops in the affected eye(s) as needed.

INACTIVE INGREDIENT SECTION

Inactive ingredients

benzalkonium chloride, boric acid, calcium chloride dihydrate, erythritol, levocarnitine, magnesium chloride, potassium chloride, purified water, sodium borate, sodium citrate dihydrate

DOSAGE & ADMINISTRATION SECTION

DISTRIBUTED BY CARDINAL HEALTH

DUBLIN, OHIO 43017

CIN 4290763

www.myleader.com

1-800-200-6313

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

image description

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
37205-635-05	2025-04-23	C162847	48780-1	9d75b9cf-d6a0-f424-e053-dadaa90a57ce	0b1b3484-be16-45ba-a0b0-deb59f31fd84
37205-635-05	2020-01-31	C162847	48780-1	9d75b9cf-d6a0-f424-e053-dadaa90a57ce	0b1b3484-be16-45ba-a0b0-deb59f31fd84

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
37205-635-05	ML - Milliliter	37205-635	64c8f851-fbee-40e9-a45f-10607f49813b	1	2014-07-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
CARBOXYMETHYLCELLULOSE SODIUM	ACTIVE INGREDIENT	K679OBS311	9
GLYCERIN	ACTIVE INGREDIENT	PDC6A3C0OX	9
CARBOXYMETHYLCELLULOSE	ACTIVE MOIETY	05JZI7B19X	9
GLYCERIN	ACTIVE MOIETY	PDC6A3C0OX	9
BENZALKONIUM CHLORIDE	INACTIVE INGREDIENT	F5UM2KM3W7	9
BORIC ACID	INACTIVE INGREDIENT	R57ZHV85D4	9
CALCIUM CHLORATE DIHYDRATE	INACTIVE INGREDIENT	BBB2RG413E	9
ERYTHRITOL	INACTIVE INGREDIENT	RA96B954X6	9
LEVOCARNITINE	INACTIVE INGREDIENT	0G389FZZ9M	9
MAGNESIUM CHLORIDE	INACTIVE INGREDIENT	02F3473H9O	9
POTASSIUM CHLORIDE	INACTIVE INGREDIENT	660YQ98I10	9
SODIUM BORATE	INACTIVE INGREDIENT	91MBZ8H3QO	9
WATER	INACTIVE INGREDIENT	059QF0KO0R	9

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 14 matching rows.

LEADER LUBRICATING EYE
CARBOXYMETHYLCELLULOSE SODIUM, AND GLYCERIN
CARBOXYMETHYLCELLULOSE SODIUM
CARBOXYMETHYLCELLULOSE
GLYCERIN
BENZALKONIUM CHLORIDE
BORIC ACID
CALCIUM CHLORATE DIHYDRATE
ERYTHRITOL
LEVOCARNITINE
MAGNESIUM CHLORIDE
POTASSIUM CHLORIDE
WATER
SODIUM BORATE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
37205-635	37205-635-05

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
CARBOXYMETHYLCELLULOSE SODIUM	K679OBS311	ACTIB
GLYCERIN	PDC6A3C0OX	ACTIB
BENZALKONIUM CHLORIDE	F5UM2KM3W7	IACT
BORIC ACID	R57ZHV85D4	IACT
CALCIUM CHLORATE DIHYDRATE	BBB2RG413E	IACT
ERYTHRITOL	RA96B954X6	IACT
LEVOCARNITINE	0G389FZZ9M	IACT
MAGNESIUM CHLORIDE	02F3473H9O	IACT
POTASSIUM CHLORIDE	660YQ98I10	IACT
WATER	059QF0KO0R	IACT
SODIUM BORATE	91MBZ8H3QO	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 72 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
BORIC ACID	BORIC ACID	R57ZHV85D4	SUSPENSION / AURICULAR (OTIC)	0.6 %w/v		Exact identifier — unii candidate 17 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	CLOTH / TOPICAL	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	POWDER / NASAL	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SUSPENSION / OPHTHALMIC		1 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	SUSPENSION / OPHTHALMIC	0.03 %w/w		Exact identifier — unii candidate 18 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	POWDER / RESPIRATORY (INHALATION)	0.18 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
MAGNESIUM CHLORIDE	MAGNESIUM CHLORIDE	02F3473H9O	SOLUTION / INTRAOCULAR		15 mg	Exact identifier — unii candidate 7 equally ranked IID candidates
BORIC ACID	BORIC ACID	R57ZHV85D4	SUSPENSION/ DROPS / OPHTHALMIC		22 mg	Exact identifier — unii candidate 17 equally ranked IID candidates
MAGNESIUM CHLORIDE	MAGNESIUM CHLORIDE	02F3473H9O	SOLUTION/ DROPS / OPHTHALMIC	0.03 %w/v		Exact identifier — unii candidate 7 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	INJECTION, SOLUTION / INTRAVENOUS		330 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SOLUTION / OPHTHALMIC	2 %w/v		Exact identifier — unii candidate 24 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SOLUTION / NASAL	40.46 mg/100ml		Exact identifier — unii candidate 24 equally ranked IID candidates
BORIC ACID	BORIC ACID	R57ZHV85D4	MOUTHWASH / BUCCAL	7.36 mg/1ml		Exact identifier — unii candidate 17 equally ranked IID candidates
BORIC ACID	BORIC ACID	R57ZHV85D4	INJECTION, SOLUTION / INTRAVENOUS		210 mg	Exact identifier — unii candidate 17 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SOLUTION/ DROPS / TOPICAL	0.01 %w/v		Exact identifier — unii candidate 24 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	INJECTION / INTRA-ARTICULAR		1 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SOLUTION / TOPICAL	0.02 %w/v		Exact identifier — unii candidate 24 equally ranked IID candidates
BORIC ACID	BORIC ACID	R57ZHV85D4	SOLUTION / AURICULAR (OTIC)	0.05 %w/w		Exact identifier — unii candidate 17 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	SOAP / TOPICAL	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	LOTION / TOPICAL	0.1 %w/w		Exact identifier — unii candidate 24 equally ranked IID candidates
SODIUM BORATE	SODIUM BORATE	91MBZ8H3QO	SUSPENSION/ DROPS / OPHTHALMIC	0.03 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SOLUTION/ DROPS / OPHTHALMIC		1 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SOLUTION / AURICULAR (OTIC)	0.01 %w/v		Exact identifier — unii candidate 24 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	SOLUTION / IRRIGATION	0.04 %w/v		Exact identifier — unii candidate 18 equally ranked IID candidates
MAGNESIUM CHLORIDE	MAGNESIUM CHLORIDE	02F3473H9O	INJECTION, SUSPENSION / INTRAVITREAL	0.03 %w/v		Exact identifier — unii candidate 7 equally ranked IID candidates
BORIC ACID	BORIC ACID	R57ZHV85D4	DROPS / OPHTHALMIC	1 %w/w		Exact identifier — unii candidate 17 equally ranked IID candidates
SODIUM BORATE	SODIUM BORATE	91MBZ8H3QO	EMULSION / OPHTHALMIC	0.11 %w/v		Exact identifier — unii candidate 6 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	SOLUTION / INTRAOCULAR		38 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SPRAY, METERED / NASAL		1 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	INJECTION / INTRALESIONAL		1 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	INJECTION / INTRAMUSCULAR	0.4 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SUSPENSION/ DROPS / OPHTHALMIC	0.02 %w/v		Exact identifier — unii candidate 24 equally ranked IID candidates
BORIC ACID	BORIC ACID	R57ZHV85D4	SOLUTION/ DROPS / OPHTHALMIC		48 mg	Exact identifier — unii candidate 17 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	INJECTION / INFILTRATION	0.3 mg		Exact identifier — unii candidate 18 equally ranked IID candidates
BORIC ACID	BORIC ACID	R57ZHV85D4	SUSPENSION/ DROPS / AURICULAR (OTIC)		3 mg	Exact identifier — unii candidate 17 equally ranked IID candidates
MAGNESIUM CHLORIDE	MAGNESIUM CHLORIDE	02F3473H9O	SOLUTION / OPHTHALMIC	0.01 %w/v		Exact identifier — unii candidate 7 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	INJECTION / INTRAVENOUS		1 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SUSPENSION/ DROPS / TOPICAL	NA		Exact identifier — unii candidate 24 equally ranked IID candidates
MAGNESIUM CHLORIDE	MAGNESIUM CHLORIDE	02F3473H9O	SOLUTION / INTRAPERITONEAL	0.01 %w/v		Exact identifier — unii candidate 7 equally ranked IID candidates
SODIUM BORATE	SODIUM BORATE	91MBZ8H3QO	CREAM / TOPICAL	NA		Exact identifier — unii candidate 6 equally ranked IID candidates
MAGNESIUM CHLORIDE	MAGNESIUM CHLORIDE	02F3473H9O	INJECTION, SOLUTION / INTRATHECAL		1 mg	Exact identifier — unii candidate 7 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SHAMPOO / TOPICAL	0.2 %w/w		Exact identifier — unii candidate 24 equally ranked IID candidates
BORIC ACID	BORIC ACID	R57ZHV85D4	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	0.53 %w/v		Exact identifier — unii candidate 17 equally ranked IID candidates
SODIUM BORATE	SODIUM BORATE	91MBZ8H3QO	SOLUTION / AURICULAR (OTIC)	0.3 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	CAPSULE, DELAYED RELEASE / ORAL		2 mg	Exact identifier — unii candidate 18 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	SOLUTION / OPHTHALMIC	0.22 %w/v		Exact identifier — unii candidate 18 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	OINTMENT / TOPICAL	0.03 %w/w		Exact identifier — unii candidate 24 equally ranked IID candidates
BORIC ACID	BORIC ACID	R57ZHV85D4	GEL / OPHTHALMIC	0.5 %w/w		Exact identifier — unii candidate 17 equally ranked IID candidates
BORIC ACID	BORIC ACID	R57ZHV85D4	SOLUTION / OPHTHALMIC		60 mg	Exact identifier — unii candidate 17 equally ranked IID candidates
BORIC ACID	BORIC ACID	R57ZHV85D4	EMULSION / TOPICAL	1.3 %w/w		Exact identifier — unii candidate 17 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SUSPENSION/ DROPS / AURICULAR (OTIC)	0.02 %w/v		Exact identifier — unii candidate 24 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	INJECTION, SUSPENSION / INTRAVITREAL	0.08 %w/v		Exact identifier — unii candidate 18 equally ranked IID candidates
BORIC ACID	BORIC ACID	R57ZHV85D4	SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC	0.3 %w/w		Exact identifier — unii candidate 17 equally ranked IID candidates
BORIC ACID	BORIC ACID	R57ZHV85D4	EMULSION / OPHTHALMIC	0.3 %w/v		Exact identifier — unii candidate 17 equally ranked IID candidates
POTASSIUM CHLORIDE	POTASSIUM CHLORIDE	660YQ98I10	SUSPENSION / ORAL	NA		Exact identifier — unii candidate 18 equally ranked IID candidates
MAGNESIUM CHLORIDE	MAGNESIUM CHLORIDE	02F3473H9O	SUSPENSION / AURICULAR (OTIC)	0.06 %w/w		Exact identifier — unii candidate 7 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	GEL / OPHTHALMIC	0.01 %w/w		Exact identifier — unii candidate 24 equally ranked IID candidates
BORIC ACID	BORIC ACID	R57ZHV85D4	SUSPENSION/ DROPS / TOPICAL	0.3 %w/v		Exact identifier — unii candidate 17 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	INJECTION / INTRAMUSCULAR		1 mg	Exact identifier — unii candidate 24 equally ranked IID candidates
BENZALKONIUM CHLORIDE	BENZALKONIUM CHLORIDE	F5UM2KM3W7	SPRAY / NASAL		1 mg	Exact identifier — unii candidate 24 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
9f97cd6f-7478-449e-92db-96ecb3bd9064			0b1b3484-be16-45ba-a0b0-deb59f31fd84	2025-04-16	Warnings	Exact identifier spl set id: 0b1b3484-be16-45ba-a0b0-deb59f31fd84

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.